CD Genomics is committed to offering advanced next generation sequencing (NGS) strategy to help researchers screening the phage display libraries in a high-throughput manner, enabling you to preserve the diversity of antibody libraries and quickly select the plurality of related antibodies as well as rare phages in a large population that can be recovered and tested for activity. Illumina deep-sequencing provides many advantages to phage display library screening, especially for the large sequence collection. https://www.cd-genomics.com/antibody-screening-sequencing.html